Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk ...

CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.

President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.

Trump, along with billionaire Elon Musk, is moving rapidly to shrink the federal workforce, raise barriers to trade and immigration, and expand the White House’s control of government agencies.

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.